Jobs
View more job listings or post a job
Bioduro-Sundia Associate Director/Director in Laboratory Animal and Exploratory Toxicology
Variant Bio (Senior) Scientist - DMPK
Alturas Analytics Scientist 1
University of California, Davis TOXICOLOGY ANALYTICAL CHEMIST (STAFF RESEARCH ASSOCIATE 3)
University of California, Davis CALIFORNIA ANIMAL HEALTH AND FOOD SAFETY LABORATORY - TOXICOLOGY LAB RESEARCH SUPERVISOR/GROUP LEADER
Eli Lilly and Company R-39973 Scientific Director ADME - Novel Modalities (Open)
FibroGen Director DMPK
Applied BioMath Technical Marketing Specialist
Horizon Therapeutics Director, Bioanalytical Sciences
Exelixis Principal Scientist - DMPK
Post a job


Position:
Director Clinical Pharmacology

Employer:
Nikang Therapeutics

Description:

Job Summary

NiKang Therapeutics has an opening for the Director, Clinical Pharmacology. In this position, you will report to the Vice President, Clinical Pharmacology & DMPK. You will be responsible for the Clinical Pharmacology plan for assigned projects and serve as the Clinical Pharmacology lead in project and study teams. You will collaborate with cross-functional teams to identify and mitigate challenges related to all aspects of clinical pharmacology.

This will be a remote working position that requires minimal travel.

Essential Duties and Responsibilities

  • Draft and update Clinical Pharmacology plans and design Clinical Pharmacology studies
  • Apply model-informed drug development for dosage optimization at all stages of clinical development based on nonclinical and clinical data
  • Contribute to key clinical and regulatory documents (e.g., study protocols, study reports, IBs, DSURs/PSURs, INDs, NDAs, MAAs) and address Clinical Pharmacology-related regulatory questions
  • Partner with cross-function teams to advance projects
  • Oversee outsourced Clinical Pharmacology related work


Qualifications/Experience:

JOB QUALIFICATIONS

  • Ph.D. or Pharma D. degree in pharmacokinetics, clinical pharmacology, or relevant biological sciences with at least 6 years of experience of pharmacokinetics and clinical pharmacology in the small molecule drug development
  • Well informed with the current FDA, EMA, ICH guidances on DMPK and Clinical Pharmacology
  • Extensive experience in designing clinical PK protocols, performing PK/PD analysis, and interpreting the impact of study results on clinical programs
  • Hands-on experience in quantitative modeling methods (e.g., population PK, exposure-response analysis, PBPK) and modeling tools (e.g., NONMEM, WinNonlin, R, etc.)
  • At least 5 years working experience in oncology and/or anti-inflammation drug development
  • Hands-on experience in NDA/MAA filing and regulatory interactions are highly preferred, but not required.
  • Strong trouble shooting and problem-solving skills and ability.
  • Capability to mentor junior scientists and provide cross-functional education.
  • Excellent oral and written communication skills and an ability to influence.
  • Good network with scientific leaders and CROs.

NiKang Therapeutics is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants and complies with all applicable national, state and local laws governing nondiscrimination in employment.

 



Location: Flexible

Contact: jim.xiao@nikangtx.com

Post Date: 7/9/2022 10:54:54 AM
©Pharmaceutical & BioScience Society, International; Last Modified: 4/25/2024; Admin Logon
Ads (in random order)
Submit a Text Ad
($250 for 2 months)

Alturas Analytics, Inc. Expert Regulated & Non-Regulated LC-MS, GC-MS bioanalytical & PK/TK analysis of small & large molecules in any matrix. Discovery through phase IV.
Lena Biosciences Predictive toxicology. Mitochondrial toxicity in a drug metabolism-competent model with active transporters. Intrinsic & idiosyncratic DILI.
Lena Biosciences Predictive toxicology. Intrinsic & idiosyncratic drug-induced liver injury. Mitochondrial toxicity in a drug metabolism-competent model.
Hypha Discovery Synthesis, purification & NMR characterization of phase I and II drug metabolites & API impurities at mg-g scale with COAs.
Submit a Text Ad